Evidence map›Paper›PMID 38740738›Full record

ArticleNature communications2024

Rapid and scalable photocatalytic C(sp

Ting Wan, Luca Capaldo, Jonas Djossou, Angela Staffa, Felix J de Zwart, Bas de Bruin, Timothy Noël

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ting Wan *Flow Chemistry Group, van't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, 1098, XH, Amsterdam, The Netherlands.
Luca Capaldo *Flow Chemistry Group, van't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, 1098, XH, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-7114-267X
Jonas DjossouFlow Chemistry Group, van't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, 1098, XH, Amsterdam, The Netherlands.
Angela StaffaFlow Chemistry Group, van't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, 1098, XH, Amsterdam, The Netherlands.
Felix J de ZwartHomogeneous, Supramolecular and Bioinspired Catalysis Group (HomKat), van't Hoff Institute for Molecular Sciences (HIMS), Universiteit van Amsterdam (UvA), 1098, XH, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0981-1120
Bas de BruinHomogeneous, Supramolecular and Bioinspired Catalysis Group (HomKat), van't Hoff Institute for Molecular Sciences (HIMS), Universiteit van Amsterdam (UvA), 1098, XH, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-3482-7669
Timothy NoëlFlow Chemistry Group, van't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, 1098, XH, Amsterdam, The Netherlands. t.noel@uva.nl.ORCID http://orcid.org/0000-0002-3107-6927

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, there has been a growing demand for drug design approaches that incorporate a higher number of sp

Identifiers

PMID38740738
PMCPMC11091139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.